ED2 LONG-TERM COST-UTILITY ANALYSIS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN INTYPE 2 DIABETES PATIENTS IN THE GERMAN SETTING
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64859-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64859-0/fulltext
Title :
ED2 LONG-TERM COST-UTILITY ANALYSIS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN INTYPE 2 DIABETES PATIENTS IN THE GERMAN SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64859-0&doi=10.1016/S1098-3015(10)64859-0
First page :
Section Title :
Open access? :
No
Section Order :
18